Authors:
Diekema, DJ
Beach, ML
Pfaller, MA
Jones, RN
Citation: Dj. Diekema et al., Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America, CL MICRO IN, 7(3), 2001, pp. 152-157
Authors:
Diekema, DJ
Pfaller, MA
Schmitz, FJ
Smayevsky, J
Bell, J
Jones, RN
Beach, M
Citation: Dj. Diekema et al., Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999, CLIN INF D, 32, 2001, pp. S114-S132
Authors:
Pfaller, MA
Diekema, DJ
Jones, RN
Sader, HS
Fluit, AC
Hollis, RJ
Messer, SA
Citation: Ma. Pfaller et al., International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program, J CLIN MICR, 39(9), 2001, pp. 3254-3259
Authors:
Yamazumi, T
Furuta, I
Diekema, DJ
Pfaller, MA
Jones, RN
Citation: T. Yamazumi et al., Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci, J CLIN MICR, 39(10), 2001, pp. 3633-3636
Authors:
Yamazumi, T
Marshall, SA
Wilke, WW
Diekema, DJ
Pfaller, MA
Jones, RN
Citation: T. Yamazumi et al., Comparison of the vitek Gram-Positive Susceptibility 106 Card and the MRSA-Screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus, J CLIN MICR, 39(1), 2001, pp. 53-56
Authors:
Xiang, JH
Wunschmann, S
Diekema, DJ
Klinzman, D
Patrick, KD
George, SL
Stapleton, JT
Citation: Jh. Xiang et al., Effect of coinfection with GB virus C on survival among patients with HIV infection., N ENG J MED, 345(10), 2001, pp. 707-714
Authors:
Diekema, DJ
Pfaller, MA
Jones, RN
Doern, GV
Kugler, KC
Beach, ML
Sader, HS
Citation: Dj. Diekema et al., Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America, INT J ANT A, 13(4), 2000, pp. 257-271
Authors:
Andrews, JI
Diekema, DJ
Hunter, SK
Rhomberg, PR
Pfaller, MA
Jones, RN
Doern, GV
Citation: Ji. Andrews et al., Group B streptococci causing neonatal bloodstream infection: Antimicrobialsusceptibility and serotyping results from SENTRY centers in the Western Hemisphere, AM J OBST G, 183(4), 2000, pp. 859-862
Authors:
Diekema, DJ
Pfaller, MA
Jones, RN
Doern, GV
Winokur, PL
Gales, AC
Sader, HS
Kugler, K
Beach, M
Citation: Dj. Diekema et al., Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997, CLIN INF D, 29(3), 1999, pp. 595-607
Citation: Lm. Deshpande et al., Comparative activity of clinafloxacin AND nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals, DIAG MICR I, 35(1), 1999, pp. 81-88
Citation: Dj. Diekema et al., Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers, DIAG MICR I, 34(1), 1999, pp. 37-43
Authors:
Diekema, DJ
Pfaller, MA
Messer, SA
Houston, A
Hollis, RJ
Doern, GV
Jones, RN
Citation: Dj. Diekema et al., In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY antimicrobial surveillance program in North America and Latin America, ANTIM AG CH, 43(9), 1999, pp. 2236-2239
Authors:
Diekema, DJ
Coffman, SL
Marshall, SA
Beach, ML
Rolston, KVI
Jones, RN
Citation: Dj. Diekema et al., Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centers, ANTIM AG CH, 43(4), 1999, pp. 940-943